Ocumension Therapeutics (01477)
| Director | From | To | Position(s) | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|---|
| Cao Yanling | 18-Jun-19 | NED | |||
| Chau Anita Hing Ling | 15-Jun-22 | 30-Sep-23 | CoSec | ||
| Chen Lian Yong | 20-Jul-21 | Ch, NED | |||
| 23-May-18 | 20-Jul-21 | Ch | |||
| Chen Tingchan | 30-Sep-23 | CoSec | |||
| He Lianming | 23-Jun-20 | 30-Mar-22 | INED | ||
| Hu Zhaopeng | 24-Apr-20 | ED | |||
| Huang Yiran | 23-Jun-20 | INED | |||
| Ji Yun | 28-Apr-20 | 30-Sep-23 | CoSec | ||
| Li Wei | 20-Jul-21 | 16-Jan-25 | NED | ||
| 13-Apr-18 | 20-Jul-21 | ED | |||
| Liu Ye | 23-Nov-18 | CEO | |||
| Qin Xie | 30-Jun-25 | MbNC | |||
| Ruan Tim | 30-Sep-23 | CoSec | |||
| Suen Hannah Pui Chun | 12-Mar-20 | 15-Jun-22 | CoSec | ||
| Sun Lefei | 24-Apr-20 | 19-Mar-21 | NED | ||
| Ting Yuk Anthony Wu | 30-Jun-25 | MbNC | |||
| Tingchan Chen | 30-Jun-26 | CoSec, AuRep | |||
| Wang Yumeng | 19-Mar-21 | 21-Oct-24 | NED | ||
| Wu Anthony Ting Yuk | 23-Jun-20 | INED | |||
| Xie Qin | 16-Jan-25 | NED | |||
| Zhang Zhenyu | 08-Apr-22 | INED | |||
| Zhuang Beibei | 30-Jun-26 | INED, ChAC, MbCC, MbNC |